Back to results
US 7,018,818 B2Granted
Intermediates in the preparation of therapeutic fused bicyclic amino acids
AssigneePfizer Inc.
InventorsIain Robert Gladwell, Alan John Pettman
Life of this patent
Estimating the term…
Abstract
The invention presents compounds of formula (I), where R represents H or a suitable carboxylic acid protecting group, which are intermediates in the preparation of therapeutic fused bicyclic amino acids.
Claims4
A process for the preparation of a compound of formula (IV) or (IVA)
- from a compound of formula (I) or (IA)
- where R represents H or a suitable carboxylic acid protecting group comprising the reaction:
- (i) where R is H, enzymatic hydrolysis of a compound of formula (I) or (IA), where R is a carboxylic acid protecting group;
- or
- (ii) where R is a carboxylic acid protecting group, enzymatic esterification of a compound of formula (I) or (IA) where R is H;
- or
- (iii) chromatographic resolution of the isomers of a compound of formula (I) or (IA);
- or
- (iv) where R is a carboxylic acid protecting group, by enzymatic hydrolysis of a compound of formula (I) or (IA) where R is a carboxylic acid protecting group, followed by re-esterificarion;
- or
- (v) where R is a carboxylic acid protecting group, by removal of the undesired stereoisomer of a compound of formula (I) or (IA) where R is a carboxylic acid protecting group by enzymatic hydrolysis.
8 more elements
Dependencies are inferred from the claim text.